ADAR1 Capital Management, LLC
An institutional investment manager in AUSTIN, TX. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1940272.
- Reported value$2.19bn
- Positions277
Holdings: 277 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Abivax SAABVX | SPONSORED ADS | 00370M103 | 240 | 11.0% | 1,804,703 | Added+410,684 | |
| Protagonist Therapeutics IncPTGX | COM | 74366E102 | 118 | 5.4% | 960,863 | Reduced−33,256 | |
| Roivant Sciences Ltd | SHS | G76279101 | 112 | 5.1% | 3,157,008 | Reduced−128,898 | |
| State STR SPDR S&P 500 ETF TSPY | TR UNIT | 78462F103 | 96.4 | 4.4% | 129,087 | Added+53,147 | |
| Immunovant IncIMVT | COM | 45258J102 | 89.8 | 4.1% | 2,330,716 | Reduced−348,294 | |
| ZAI Lab LtdZLAB | ADR | 98887Q104 | 64.0 | 2.9% | 3,369,034 | Added+1,943,667 | |
| Agios Pharmaceuticals IncAGIO | COM | 00847X104 | 47.8 | 2.2% | 1,288,053 | Added+1,147,381 | |
| Crinetics Pharmaceuticals in | COM | 22663K107 | 45.7 | 2.1% | 1,222,080 | Added+82,749 | |
| EA Series Trust | ALPHA ARCH 1-3 | 02072L565 | 39.5 | 1.8% | 337,125 | Unchanged | |
| Cytokinetics IncCYTK | COM NEW | 23282W605 | 39.0 | 1.8% | 457,907 | Reduced−174,649 | |
| Septerna IncSEPN | COM | 81734D104 | 31.5 | 1.4% | 940,747 | Reduced−149,071 | |
| Anteris Technologies GlobalAVR | COM | 03675P102 | 31.0 | 1.4% | 3,145,096 | Reduced−644,036 | |
| Editas Medicine IncEDIT | COM | 28106W103 | 28.8 | 1.3% | 8,889,000 | New+8,889,000 | |
| Denali Therapeutics IncDNLI | COM | 24823R105 | 26.5 | 1.2% | 1,029,080 | Reduced−842,375 | |
| Spyre Therapeutics IncSYRE | COM NEW | 00773J202 | 25.2 | 1.2% | 283,982 | Reduced−54,341 | |
| VIR Biotechnology IncVIR | COM | 92764N102 | 25.0 | 1.1% | 2,456,677 | Reduced−288,037 | |
| Praxis Precision Medicines IPRAX | COM NEW | 74006W207 | 24.9 | 1.1% | 74,253 | Added+72,753 | |
| Insmed IncINSM | COM PAR $.01 | 457669307 | 24.4 | 1.1% | 228,520 | Added+193,128 | |
| Celldex Therapeutics Inc NewCLDX | COM NEW | 15117B202 | 23.1 | 1.1% | 619,542 | Added+191,726 | |
| Viking Therapeutics IncVKTX | COM | 92686J106 | 22.4 | 1.0% | 574,038 | Added+346,321 | |
| Taysha Gene Therapies IncTSHA | COM SHS | 877619106 | 20.7 | 0.9% | 3,040,466 | Added+61,037 | |
| Monopar Therapeutics IncMNPR | COM NEW | 61023L207 | 20.1 | 0.9% | 217,595 | Reduced−46,683 | |
| Ovid Therapeutics IncOVID | COM | 690469101 | 20.0 | 0.9% | 7,417,479 | Added+2,873,366 | |
| Enliven Therapeutics IncELVN | COM | 29337E102 | 19.7 | 0.9% | 387,718 | Added+58,178 | |
| Enanta Pharmaceuticals IncENTA | COM | 29251M106 | 19.6 | 0.9% | 1,344,510 | Added+1,293,153 | |
| Ishares TR | RUSSELL 2000 ETF | 464287655 | 18.8 | 0.9% | 62,500 | Put | Added+35,000 |
| State STR SPDR S&P 500 ETF TSPY | TR UNIT | 78462F103 | 18.7 | 0.9% | 25,000 | Put | New+25,000 |
| Nektar TherapeuticsNKTR | COM NEW | 640268306 | 17.0 | 0.8% | 244,184 | Added+82,932 | |
| Inspire Med Sys IncINSP | COM | 457730109 | 16.7 | 0.8% | 374,617 | Reduced−30,580 | |
| Revolution Medicines IncRVMD | COM | 76155X100 | 16.4 | 0.7% | 87,509 | Reduced−46,384 | |
| Establishment Labs Holdings Inc | COM | G31249108 | 15.9 | 0.7% | 185,619 | Reduced−27,854 | |
| Prothena Corp plc | SHS | G72800108 | 15.2 | 0.7% | 1,554,535 | Reduced−26,908 | |
| Rhythm Pharmaceuticals IncRYTM | COM | 76243J105 | 15.1 | 0.7% | 136,158 | Reduced−75,292 | |
| Inhibikase Therapeutics IncIKT | COM NEW | 45719W205 | 15.0 | 0.7% | 7,387,205 | Added+780,633 | |
| Uniqure NV | SHS | N90064101 | 15.0 | 0.7% | 324,672 | Added+248,466 | |
| Rallybio CorpRLYB | COM | 75120L209 | 14.8 | 0.7% | 926,352 | Added+905,817 | |
| Regeneron PharmaceuticalsREGN | COM | 75886F107 | 13.8 | 0.6% | 22,208 | Added+10,054 | |
| Inventiva SAIVA | ADS | 46124U107 | 13.6 | 0.6% | 3,606,656 | Added+1,432,258 | |
| Sutro Biopharma IncSTRO | COM SHS | 869367201 | 13.4 | 0.6% | 404,014 | Reduced−120,427 | |
| Ionis Pharmaceuticals IncIONS | COM | 462222100 | 13.2 | 0.6% | 166,286 | Added+5,948 | |
| Bridgebio Pharma IncBBIO | COM | 10806X102 | 13.2 | 0.6% | 176,689 | Added+82,397 | |
| Sarepta Therapeutics IncSRPT | COM | 803607100 | 13.1 | 0.6% | 730,649 | Added+468,591 | |
| Cytomx Therapeutics Inc.CTMX | COM | 23284F105 | 12.6 | 0.6% | 3,365,118 | Reduced−45,072 | |
| VOR Biopharma IncVOR | COM NEW | 929033207 | 12.5 | 0.6% | 680,626 | New+680,626 | |
| SPDR Series Trust | ST STR BLO 1 ETF | 78468R663 | 12.4 | 0.6% | 135,585 | Unchanged | |
| Equillium IncEQ | COM | 29446K106 | 12.0 | 0.6% | 3,758,569 | Added+31,910 | |
| Adlai Nortye LtdANL | SPONSORED ADS | 00704R109 | 11.7 | 0.5% | 1,017,805 | Added+899,896 | |
| Climb Bio IncCLYM | COM | 28658R106 | 10.7 | 0.5% | 822,649 | Added+224,987 | |
| SPDR Series Trust | ST STR SP BIOT | 78464A870 | 10.7 | 0.5% | 67,400 | Put | Added+52,400 |
| Helix Acquisition Corp III | USD CL A ORD SHS | G4444S107 | 10.6 | 0.5% | 1,000,000 | Unchanged | |
| Zura Bio Ltd | CLASS A ORD SHS | G9TY5A101 | 10.4 | 0.5% | 1,759,295 | Added+1,128,892 | |
| Onkure Therapeutics IncOKUR | COM CL A | 68277Q105 | 10.2 | 0.5% | 2,238,684 | Reduced−196,257 | |
| Maze Therapeutics IncMAZE | COM | 578784100 | 10.1 | 0.5% | 339,276 | Added+289,181 | |
| Xenon Pharmaceuticals IncXENE | COM | 98420N105 | 10.1 | 0.5% | 166,550 | Reduced−62,349 | |
| Teva Pharmaceutical Inds Ltd | SPONSORED ADS | 881624209 | 9.4 | 0.4% | 277,848 | Added+9,457 | |
| Urogen Pharma Ltd | COM | M96088105 | 9.3 | 0.4% | 252,395 | Reduced−143,064 | |
| Faeth Therapeutics IncFTH | COM NEW | 81728A207 | 9.0 | 0.4% | 361,010 | New+361,010 | |
| Amylyx Pharmaceuticals IncAMLX | COM | 03237H101 | 8.9 | 0.4% | 494,378 | Reduced−506,226 | |
| DBV Technologies S aDBVT | SPONSORED ADS | 23306J309 | 8.7 | 0.4% | 528,295 | Reduced−484,571 | |
| Savara IncSVRA | COM | 805111101 | 8.6 | 0.4% | 1,403,409 | Reduced−61,126 | |
| Vaxcyte IncPCVX | COM | 92243G108 | 8.5 | 0.4% | 146,034 | Reduced−113,103 | |
| CG Oncology IncCGON | COM | 156944100 | 8.4 | 0.4% | 118,664 | Reduced−67,035 | |
| Mineralys Therapeutics IncMLYS | COM | 603170101 | 8.1 | 0.4% | 298,886 | Added+144,200 | |
| Ascendis Pharma A/S | ORD SHS | K08588103 | 7.6 | 0.3% | 28,604 | New+28,604 | |
| Amanat Acquisition Corp | CL A ORD | G0375M101 | 7.6 | 0.3% | 750,000 | New+750,000 | |
| Nurix Therapeutics IncNRIX | COM | 67080M103 | 7.6 | 0.3% | 313,236 | Added+257,166 | |
| Biohaven Ltd | COM | G1110E107 | 7.5 | 0.3% | 501,687 | Added+456,910 | |
| Prime Medicine IncPRME | COM | 74168J101 | 7.4 | 0.3% | 1,997,552 | Added+24,270 | |
| Perceptive Cap Solutions Cor | CL A ORD SHS | G70077105 | 7.3 | 0.3% | 674,695 | Added+175,114 | |
| Opus Genetics IncIRD | COM | 67577R102 | 7.3 | 0.3% | 1,783,781 | Reduced−65,223 | |
| Lexeo Therapeutics IncLXEO | COM | 52886X107 | 7.3 | 0.3% | 1,565,950 | Added+98,600 | |
| Damora Therapeutics Inc | COM NEW | 36322Q206 | 7.3 | 0.3% | 280,000 | Added+1,000 | |
| Replimune Group IncREPL | COM | 76029N106 | 7.3 | 0.3% | 655,784 | Reduced−927,203 | |
| Leonabio IncLONA | COM | 04746L203 | 7.1 | 0.3% | 777,100 | Added+49,619 | |
| Korro Bio IncKRRO | COM | 500946108 | 7.1 | 0.3% | 540,054 | Unchanged | |
| Research Alliance Corp III | ORD SHS CL A | G75226103 | 7.0 | 0.3% | 650,000 | New+650,000 | |
| Inflarx NV | COM | N44821101 | 6.7 | 0.3% | 3,000,000 | Added+2,841,729 | |
| Relay Therapeutics IncRLAY | COM | 75943R102 | 6.7 | 0.3% | 358,333 | New+358,333 | |
| Janux Therapeutics IncJANX | COM | 47103J105 | 6.5 | 0.3% | 420,881 | Added+122,335 | |
| Pliant Therapeutics IncPLRX | COM | 729139105 | 6.3 | 0.3% | 5,509,724 | Added+2,924,598 | |
| Whitehawk Therapeutics IncWHWK | COM | 00032Q104 | 6.1 | 0.3% | 1,341,394 | Added+1,212,891 | |
| Krystal Biotech IncKRYS | COM | 501147102 | 6.1 | 0.3% | 16,420 | Reduced−3,594 | |
| Arbutus Biopharma CorpABUS | COM | 03879J100 | 6.1 | 0.3% | 1,268,147 | Reduced−1,865,028 | |
| Pfizer IncPFE | COM | 717081103 | 6.1 | 0.3% | 252,400 | Added+175,000 | |
| Brighthouse Finl IncBHF | COM | 10922N103 | 6.0 | 0.3% | 95,523 | Unchanged | |
| Abivax SAABVX | SPONSORED ADS | 00370M103 | 5.9 | 0.3% | 44,400 | Call | Added+400 |
| Edgewise Therapeutics IncEWTX | COM | 28036F105 | 5.8 | 0.3% | 143,199 | Added+52,600 | |
| Alector IncALEC | COM | 014442107 | 5.8 | 0.3% | 2,883,583 | Added+1,833,583 | |
| Fulcrum Therapeutics IncFULC | COM | 359616109 | 5.7 | 0.3% | 1,565,029 | Added+1,434,469 | |
| Arrowhead Pharmaceuticals inARWR | COM | 04280A100 | 5.7 | 0.3% | 69,800 | Reduced−500 | |
| Acumen Pharmaceuticals IncABOS | COM | 00509G209 | 5.6 | 0.3% | 2,111,334 | Reduced−45,000 | |
| Oaktree Acquisition Corp III | UNIT 10/04/2029 | G6717R120 | 5.6 | 0.3% | 516,482 | Unchanged | |
| Globus Med IncGMED | CL A | 379577208 | 5.5 | 0.3% | 70,100 | Added+50,000 | |
| Monte Rosa Therapeutics IncGLUE | COM | 61225M102 | 5.2 | 0.2% | 216,752 | Added+1,000 | |
| Disciplined Growth | UNIT 99/99/9999 | G2775W127 | 5.0 | 0.2% | 500,000 | New+500,000 | |
| Bhav Acquisition Corp | UNIT 03/18/2031 | G1R59W127 | 5.0 | 0.2% | 495,000 | Unchanged | |
| Bridgebio Pharma Inc | NOTE 1.750% 3/0 | 10806XAJ1 | 5.0 | 0.2% | $30,000 principal | Unchanged | |
| Bridgebio Pharma Inc | NOTE 2.250% 2/0 | 10806XAD4 | 4.9 | 0.2% | $45,000 principal | Unchanged | |
| Danaher Corp DelDHR | COM | 235851102 | 4.9 | 0.2% | 25,932 | Reduced−5,000 | |
| Boundless Bio IncBOLD | COM | 10170A100 | 4.9 | 0.2% | 1,968,216 | New+1,968,216 | |
| Avalyn Pharmaceuticals IncAVLN | COM SHS | 05348Y105 | 4.8 | 0.2% | 146,447 | New+146,447 | |
| ARS Pharmaceuticals IncSPRY | COM | 82835W108 | 4.8 | 0.2% | 600,999 | Reduced−760,537 | |
| Ataibeckley Inc | COM SHS | 04650F101 | 4.8 | 0.2% | 913,242 | Unchanged | |
| Prelude Therapeutics IncPRLD | COM | 74065P101 | 4.8 | 0.2% | 900,900 | Added+748,075 | |
| Jatt II Acquisition Corp | ORD SHS | G50765109 | 4.7 | 0.2% | 417,724 | New+417,724 | |
| Rein Therapeutics IncRNTX | COM NEW | 00887A204 | 4.7 | 0.2% | 4,500,000 | New+4,500,000 | |
| Pepgen IncPEPG | COM | 713317105 | 4.7 | 0.2% | 2,591,085 | Added+983,447 | |
| Contineum Therapeutics IncCTNM | CL A | 21217B100 | 4.6 | 0.2% | 278,961 | Added+2,300 | |
| Perspective Therapeutics IncCATX | COM NEW | 46489V302 | 4.1 | 0.2% | 1,210,117 | Added+460,782 | |
| Apogee Therapeutics Inc | COM | 03770N101 | 4.1 | 0.2% | 31,000 | New+31,000 | |
| Newamsterdam Pharma Company | ORDINARY SHARES | N62509109 | 4.0 | 0.2% | 118,623 | Unchanged | |
| Corbus Pharmaceuticals HoldingsCRBP | COM NEW | 21833P301 | 4.0 | 0.2% | 421,787 | Added+90,006 | |
| Biogen IncBIIB | COM | 09062X103 | 3.9 | 0.2% | 17,900 | Added+6,900 | |
| Xencor IncXNCR | COM | 98401F105 | 3.7 | 0.2% | 232,560 | Added+138,895 | |
| Silence Therapeutics plcSLN | ADS | 82686Q101 | 3.7 | 0.2% | 338,373 | Added+166,216 | |
| Spruce Biosciences IncSPRB | COM NEW | 85209E208 | 3.7 | 0.2% | 67,717 | Added+9,117 | |
| Pharvaris N V | COM | N69605108 | 3.6 | 0.2% | 105,528 | Unchanged | |
| Engene Therapeutics IncENGN | COM | 29286X101 | 3.6 | 0.2% | 2,104,986 | New+2,104,986 | |
| Palisade Bio IncPALI | COM | 696389402 | 3.6 | 0.2% | 1,726,662 | Reduced−538,183 | |
| Protara Therapeutics IncTARA | COM STK | 74365U107 | 3.6 | 0.2% | 940,512 | Unchanged | |
| Bridgebio Pharma Inc | NOTE 2.500% 3/1 | 10806XAB8 | 3.5 | 0.2% | $20,000 principal | Unchanged | |
| Sagimet Biosciences IncSGMT | COM SER A | 786700104 | 3.4 | 0.2% | 437,500 | New+437,500 | |
| Beone Medicines LtdONC | SPONSORED ADS | 07725L102 | 3.3 | 0.2% | 11,701 | Unchanged | |
| Invivyd IncIVVD | COM | 00534A102 | 3.3 | 0.2% | 3,807,427 | Reduced−15,000 | |
| Tenax Therapeutics IncTENX | COM NEW | 88032L605 | 3.2 | 0.1% | 220,462 | Added+7,000 | |
| Zentalis Pharmaceuticals IncZNTL | COM | 98943L107 | 3.2 | 0.1% | 652,750 | Added+508,114 | |
| Relmada Therapeutics IncRLMD | COM | 75955J402 | 3.1 | 0.1% | 451,918 | Unchanged | |
| Delcath Sys IncDCTH | COM NEW | 24661P807 | 2.8 | 0.1% | 224,385 | Unchanged | |
| Biomarin Pharmaceutical IncBMRN | COM | 09061G101 | 2.8 | 0.1% | 49,000 | Added+30,800 | |
| Summit Therapeutics IncSMMT | COM | 86627T108 | 2.8 | 0.1% | 191,869 | Added+100,000 | |
| Keros Therapeutics IncKROS | COM | 492327101 | 2.6 | 0.1% | 246,818 | Added+149,500 | |
| Eledon Pharmaceuticals IncELDN | COM | 28617K101 | 2.6 | 0.1% | 647,812 | Reduced−326,609 | |
| Sanofi SASNY | SPONSORED ADR | 80105N105 | 2.4 | 0.1% | 57,100 | Reduced−259,839 | |
| American Exceptionalism Acqu | ORD CL A | G0273J101 | 2.4 | 0.1% | 205,408 | Reduced−152,131 | |
| Tango Therapeutics IncTNGX | COM | 87583X109 | 2.4 | 0.1% | 76,761 | Added+26,761 | |
| Intuitive Surgical IncISRG | COM NEW | 46120E602 | 2.4 | 0.1% | 6,030 | Added+4,200 | |
| Inovio Pharmaceuticals IncINO | COM SHS | 45773H409 | 2.4 | 0.1% | 2,143,910 | Added+673,802 | |
| Omniab IncOABI | COM | 68218J103 | 2.3 | 0.1% | 947,412 | Added+242,222 | |
| Capricor Therapeutics IncCAPR | COM NEW | 14070B309 | 2.2 | <0.1% | 90,593 | Unchanged | |
| Bright Minds Biosciences IncDRUG | COM NEW | 10919W405 | 2.1 | <0.1% | 30,300 | Reduced−3,600 | |
| Oruka Therapeutics IncORKA | COM | 687604108 | 2.0 | <0.1% | 20,840 | Unchanged | |
| Vyne Therapeutics Inc | COM | 92941V308 | 1.9 | <0.1% | 2,950,000 | Added+1,886,101 | |
| McKesson CorpMCK | COM | 58155Q103 | 1.9 | <0.1% | 2,500 | Added+1,300 | |
| Lexicon Pharmaceuticals IncLXRX | COM NEW | 528872302 | 1.8 | <0.1% | 750,000 | Unchanged | |
| Corvus Pharmaceuticals IncCRVS | COM | 221015100 | 1.7 | <0.1% | 117,101 | Added+29,200 | |
| CUE Biopharma IncCUE | COM | 22978P205 | 1.7 | <0.1% | 55,193 | New+55,193 | |
| Satellos Bioscience IncMSLE | COM | 80401L803 | 1.7 | <0.1% | 222,555 | Unchanged | |
| Kiniksa Pharmaceuticals International | ORD SHS CL A | G52694109 | 1.7 | <0.1% | 26,913 | Unchanged | |
| Connect Biopharma Holdings Ltd | SHS | G23549101 | 1.7 | <0.1% | 700,000 | Reduced−42,400 | |
| Cohen Circle Acquisit Corp I | UNIT 07/01/2030 | G2254C105 | 1.6 | <0.1% | 150,000 | Unchanged | |
| Rocket Pharmaceuticals IncRCKT | COM | 77313F106 | 1.5 | <0.1% | 435,500 | Added+3,000 | |
| First Tracks BiotherapeuticsTRAX | ORD SHS | 337185102 | 1.4 | <0.1% | 71,910 | New+71,910 | |
| Evommune IncEVMN | COM SHS | 30054Y107 | 1.4 | <0.1% | 104,035 | Reduced−80,027 | |
| C4 Therapeutics IncCCCC | COM STK | 12529R107 | 1.4 | <0.1% | 291,957 | Added+248,957 | |
| Biocryst Pharmaceuticals IncBCRX | COM | 09058V103 | 1.3 | <0.1% | 133,000 | Added+28,000 | |
| Supernus PharmaceuticalsSUPN | COM | 868459108 | 1.3 | <0.1% | 27,842 | Reduced−1,800 | |
| Novo-Nordisk a SNVO | ADR | 670100205 | 1.3 | <0.1% | 27,000 | Reduced−6,000 | |
| Avantor IncAVTR | COM | 05352A100 | 1.3 | <0.1% | 130,000 | Added+50,000 | |
| Inmed Pharmaceuticals IncINM | COM NEW | 457637700 | 1.2 | <0.1% | 800,000 | New+800,000 | |
| Promis Neurosciences IncPMN | COM SHS | 74346M505 | 1.2 | <0.1% | 92,850 | Reduced−2,500 | |
| Arrowhead Pharmaceuticals in | NOTE 1/1 | 04280AAC4 | 1.2 | <0.1% | $10,000 principal | New+10,000 | |
| Artiva Biotherapeutics IncARTV | COM | 04317A107 | 1.2 | <0.1% | 118,624 | New+118,624 | |
| Tenaya Therapeutics IncTNYA | COM | 87990A106 | 1.1 | <0.1% | 1,555,500 | Added+47,700 | |
| ALX Oncology Holdings IncALXO | COM | 00166B105 | 1.1 | <0.1% | 533,660 | New+533,660 | |
| Alexandria Real Estate Eq inARE | COM | 015271109 | 1.0 | <0.1% | 19,500 | Unchanged | |
| Cartesian Therapeutics IncRNAC | COM NEW | 816212302 | 1.0 | <0.1% | 98,877 | New+98,877 | |
| Cyclerion Therapeutics Inc | COM | 23255M204 | 1.0 | <0.1% | 298,757 | New+298,757 | |
| Electronic Arts Inc | COM | 285512109 | 1.0 | <0.1% | 4,936 | Unchanged | |
| Travere Therapeutics Inc | NOTE 0.500% 5/1 | 89422GAB3 | 1.0 | <0.1% | $10,000 principal | New+10,000 | |
| Biontech SEBNTX | SPONSORED ADS | 09075V102 | 1.0 | <0.1% | 10,600 | Added+600 | |
| Acadia Pharmaceuticals IncACAD | COM | 004225108 | 1.0 | <0.1% | 38,955 | New+38,955 | |
| Dyne Therapeutics IncDYN | COM | 26818M108 | 1.0 | <0.1% | 42,821 | Reduced−4,642 | |
| Maplight Therapeutics IncMPLT | COM | 56565P103 | 0.9 | <0.1% | 26,497 | Reduced−348,412 | |
| Structure Therapeutics IncGPCR | SPONSORED ADS | 86366E106 | 0.9 | <0.1% | 17,500 | New+17,500 | |
| Keen Vision Acquisition Corp | SHS | G52443119 | 0.9 | <0.1% | 75,000 | Call | Unchanged |
| Wave Life Sciences Ltd | SHS | Y95308105 | 0.9 | <0.1% | 160,000 | Added+115,100 | |
| Aura Biosciences IncAURA | COM | 05153U107 | 0.9 | <0.1% | 130,152 | New+130,152 | |
| Churchill Cap Corp XI | CL A ORD SHS | G2131A108 | 0.9 | <0.1% | 50,000 | New+50,000 | |
| Kazia Therapeutics LtdKZIA | SPONSORED ADS | 48669G303 | 0.9 | <0.1% | 61,550 | New+61,550 | |
| Nuvalent Inc | COM | 670703107 | 0.9 | <0.1% | 6,942 | Unchanged | |
| Larimar Therapeutics IncLRMR | COM | 517125100 | 0.8 | <0.1% | 272,745 | Added+220,000 | |
| Vera Therapeutics IncVERA | CL A | 92337R101 | 0.8 | <0.1% | 18,322 | Added+2,289 | |
| Adagio Med Holdings IncADGM | COM | 00534B100 | 0.8 | <0.1% | 1,205,447 | Unchanged | |
| Atrium Therapeutics IncRNA | COM | 04965N104 | 0.8 | <0.1% | 57,688 | Unchanged | |
| Therapeuticsmd IncTXMD | COM NEW | 88338N206 | 0.8 | <0.1% | 342,447 | Added+133,237 | |
| Ideaya Biosciences IncIDYA | COM | 45166A102 | 0.7 | <0.1% | 20,000 | Unchanged | |
| SI Bone IncSIBN | COM | 825704109 | 0.7 | <0.1% | 45,000 | Added+32,420 | |
| Amylyx Pharmaceuticals IncAMLX | COM | 03237H101 | 0.7 | <0.1% | 40,100 | Put | New+40,100 |
| Royalty Pharma plc | SHS CLASS A | G7709Q104 | 0.7 | <0.1% | 12,500 | Added+7,500 | |
| Evolus IncEOLS | COM | 30052C107 | 0.7 | <0.1% | 100,000 | Added+44,141 | |
| Ultragenyx Pharmaceutical inRARE | COM | 90400D108 | 0.7 | <0.1% | 20,000 | Call | Unchanged |
| Ibio IncIBIO | COM NEW | 451033708 | 0.7 | <0.1% | 375,531 | Reduced−94,347 | |
| Forward Air CorpFWRD | COM | 34986A104 | 0.7 | <0.1% | 48,241 | Reduced−30,000 | |
| Geron CorpGERN | COM | 374163103 | 0.6 | <0.1% | 505,817 | Added+305,817 | |
| Stryker CorporationSYK | COM | 863667101 | 0.6 | <0.1% | 2,000 | New+2,000 | |
| Novo-Nordisk a SNVO | ADR | 670100205 | 0.6 | <0.1% | 13,000 | Call | Unchanged |
| Iovance Biotherapeutics IncIOVA | COM | 462260100 | 0.6 | <0.1% | 146,090 | New+146,090 | |
| Macrogenics IncMGNX | COM | 556099109 | 0.6 | <0.1% | 129,822 | Added+89,822 | |
| Gilead Sciences IncGILD | COM | 375558103 | 0.6 | <0.1% | 4,648 | Reduced−1,703 | |
| Natera IncNTRA | COM | 632307104 | 0.6 | <0.1% | 2,147 | Unchanged | |
| Seaport Therapeutics IncSPTX | COMMON STOCK | 81221K108 | 0.6 | <0.1% | 26,000 | New+26,000 | |
| Corbus Pharmaceuticals HoldingsCRBP | COM NEW | 21833P301 | 0.6 | <0.1% | 60,000 | Call | Added+25,000 |
| Assembly Biosciences IncASMB | COM NEW | 045396207 | 0.6 | <0.1% | 20,447 | Added+500 | |
| Cybin Inc | COM NEW | 23256X407 | 0.5 | <0.1% | 81,278 | Added+50,000 | |
| Benitec Biopharma IncBNTC | COM NEW | 08205P209 | 0.5 | <0.1% | 40,000 | Added+22,500 | |
| Polypid Ltd | COM | M8001Q126 | 0.5 | <0.1% | 103,950 | Unchanged | |
| Pulmonx CorpLUNG | COM | 745848101 | 0.5 | <0.1% | 404,497 | Added+30,000 | |
| Moonlake ImmunotherapeuticsMLTX | CLASS A ORD | 61559X104 | 0.5 | <0.1% | 27,000 | Reduced−430,137 | |
| Globa Terra Acquisition Cor | UNIT 99/99/9999 | G3933N108 | 0.5 | <0.1% | 50,000 | Unchanged | |
| Traws Pharma IncTRAW | COM NEW | 68232V884 | 0.5 | <0.1% | 597,729 | Added+443,631 | |
| Wisdomtree TR | FLOATNG RAT TREA | 97717Y527 | 0.5 | <0.1% | 10,000 | Unchanged | |
| Tectonic Therapeutic IncTECX | COM | 878972108 | 0.5 | <0.1% | 14,501 | Added+1,500 | |
| Madrigal Pharmaceuticals IncMDGL | COM | 558868105 | 0.5 | <0.1% | 895 | Unchanged | |
| Arvinas IncARVN | COM | 04335A105 | 0.5 | <0.1% | 57,591 | Unchanged | |
| Orthopediatrics CorpKIDS | COM | 68752L100 | 0.5 | <0.1% | 25,000 | Added+5,155 | |
| Cogent Biosciences IncCOGT | COM | 19240Q201 | 0.5 | <0.1% | 12,200 | New+12,200 | |
| Phathom Pharmaceuticals IncPHAT | COM | 71722W107 | 0.5 | <0.1% | 42,900 | Unchanged | |
| Mirum Pharmaceuticals IncMIRM | COM | 604749101 | 0.5 | <0.1% | 3,900 | Reduced−2,300 | |
| Kiora Pharmaceuticals IncKPRX | COM | 49721T507 | 0.4 | <0.1% | 167,941 | Unchanged | |
| Kura Oncology IncKURA | COM | 50127T109 | 0.4 | <0.1% | 40,000 | Unchanged | |
| Context Therapeutics IncCNTX | COM | 21077P108 | 0.4 | <0.1% | 750,969 | Added+399,875 | |
| Ishares TR | 0-5 YR TIPS ETF | 46429B747 | 0.4 | <0.1% | 4,000 | New+4,000 | |
| Kalaris Therapeutics IncKLRS | COM | 482929106 | 0.4 | <0.1% | 100,000 | Unchanged | |
| Bicara Therapeutics IncBCAX | COM | 055477103 | 0.4 | <0.1% | 13,705 | Unchanged | |
| Merck & Co IncMRK | COM | 58933Y105 | 0.4 | <0.1% | 3,140 | Unchanged | |
| Neumora Therapeutics Inc.NMRA | COM | 640979100 | 0.4 | <0.1% | 210,000 | Added+176,900 | |
| Irhythm Holdings IncIRTC | COM | 450056106 | 0.4 | <0.1% | 3,000 | New+3,000 | |
| Achieve Life Science IncACHV | COM | 004468500 | 0.4 | <0.1% | 53,800 | Added+6,000 | |
| Alibaba Group HLDG LtdBABA | SPONSORED ADS | 01609W102 | 0.3 | <0.1% | 3,578 | Unchanged | |
| WW International IncWW | COM NEW | 98262P200 | 0.3 | <0.1% | 21,300 | Reduced−36,400 | |
| CNS Pharmaceuticals IncCNSP | COM | 18978H508 | 0.3 | <0.1% | 70,000 | New+70,000 | |
| Crescent Biopharma Inc. | COM | G2545C104 | 0.3 | <0.1% | 18,275 | Reduced−31,998 | |
| Boston Scientific CorpBSX | COM | 101137107 | 0.3 | <0.1% | 7,500 | Reduced−2,500 | |
| Altimmune IncALT | COM NEW | 02155H200 | 0.3 | <0.1% | 102,823 | New+102,823 | |
| Verastem IncVSTM | COM NEW | 92337C203 | 0.3 | <0.1% | 75,800 | Added+4,700 | |
| AN2 Therapeutics IncANTX | COM | 037326105 | 0.3 | <0.1% | 58,808 | Added+44,947 | |
| Journey Med CorpDERM | COM | 48115J109 | 0.3 | <0.1% | 39,517 | New+39,517 | |
| Procap Acquisition Corp | UNIT 05/16/2030 | G7257A113 | 0.3 | <0.1% | 26,940 | Unchanged | |
| PMV Pharmaceuticals IncPMVP | COM | 69353Y103 | 0.3 | <0.1% | 201,008 | Reduced−30,000 | |
| Compass Therapeutics IncCMPX | COM | 20454B104 | 0.3 | <0.1% | 122,132 | Reduced−16,868 | |
| Jd.Com IncJD | SPON ADS CL A | 47215P106 | 0.3 | <0.1% | 10,000 | Unchanged | |
| Rezolute IncRZLT | COM NEW | 76200L309 | 0.3 | <0.1% | 48,679 | Reduced−10,000 | |
| Anaptysbio IncANAB | COM | 032724106 | 0.2 | <0.1% | 3,698 | Unchanged | |
| Neurogene IncNGNE | COM | 64135M105 | 0.2 | <0.1% | 7,800 | New+7,800 | |
| Ishares TR | U.S. MED DVC ETF | 464288810 | 0.2 | <0.1% | 4,900 | New+4,900 | |
| Rxsight IncRXST | COM | 78349D107 | 0.2 | <0.1% | 50,000 | Added+6,750 | |
| Coya Therapeutics IncCOYA | COMMON STOCK | 22407B108 | 0.2 | <0.1% | 40,900 | Unchanged | |
| Bicycle Therapeutics plcBCYC | SPONSORED ADS | 088786108 | 0.2 | <0.1% | 50,638 | Reduced−20,660 | |
| Cantor Equity Partners VI in | CL A ORD SHS | G1828R101 | 0.2 | <0.1% | 20,000 | Unchanged | |
| Scynexis IncSCYX | COM | 811292309 | 0.2 | <0.1% | 49,387 | New+49,387 | |
| Personalis IncPSNL | COM | 71535D106 | 0.2 | <0.1% | 15,000 | Reduced−10,000 | |
| Q/C Technologies IncQCLS | COM | 62856X300 | 0.2 | <0.1% | 50,000 | Unchanged | |
| Cabaletta Bio IncCABA | COM | 12674W109 | 0.2 | <0.1% | 50,000 | New+50,000 | |
| Recursion Pharmaceuticals inRXRX | CL A | 75629V104 | 0.2 | <0.1% | 41,000 | Added+6,000 | |
| Organon & CoOGN | COMMON STOCK | 68622V106 | 0.1 | <0.1% | 10,000 | Unchanged | |
| Milestone Pharmaceuticals inMIST | COM | 59935V107 | 0.1 | <0.1% | 100,000 | Unchanged | |
| Neuphoria Therapeutics IncNEUP | COM | 64136E102 | 0.1 | <0.1% | 30,000 | Unchanged | |
| Neuronetics IncSTIM | COM | 64131A105 | 0.1 | <0.1% | 100,000 | Unchanged | |
| Chemomab Therapeutics LtdCMMB | SPONSORED ADS | 16385C203 | 0.1 | <0.1% | 80,000 | Unchanged | |
| Solidion Technology IncSTI | COM NEW | 834212201 | 0.1 | <0.1% | 13,500 | Call | Unchanged |
| Voyager Therapeutics IncVYGR | COM | 92915B106 | 0.1 | <0.1% | 35,000 | Unchanged | |
| Entrada Therapeutics IncTRDA | COM | 29384C108 | 0.1 | <0.1% | 15,500 | Reduced−15,000 | |
| Veru IncVERU | COM NEW | 92536C202 | 0.1 | <0.1% | 35,000 | Unchanged | |
| Cantor Equity Partners VII I | CL A ORD SHS | G1828W100 | 0.1 | <0.1% | 10,000 | New+10,000 | |
| Clene IncCLNN | COM NEW | 185634201 | 0.1 | <0.1% | 15,000 | New+15,000 | |
| Vistagen Therapeutics IncVTGN | COM | 92840H400 | 0.1 | <0.1% | 351,141 | Reduced−400,000 | |
| Longeveron Inc | CL A NEW | 54303L203 | 0.1 | <0.1% | 108,406 | Reduced−91,594 | |
| Biomea Fusion IncBMEA | COM | 09077A106 | 0.1 | <0.1% | 43,420 | Unchanged | |
| Lite Strategy IncLITS | COM | 55279B301 | 0.1 | <0.1% | 67,292 | Unchanged | |
| Jasper Therapeutics IncJSPR | COM NEW | 471871202 | 0.1 | <0.1% | 140,000 | Unchanged | |
| Ardelyx IncARDX | COM | 039697107 | 0.1 | <0.1% | 11,000 | Reduced−12,900 | |
| Gossamer Bio Inc | COM | 38341P102 | 0.0 | <0.1% | 212,531 | Reduced−75,000 | |
| Atyr Pharma IncATYR | COM NEW | 002120202 | 0.0 | <0.1% | 50,685 | Unchanged | |
| A Spac III Acquisition Corp | RIGHT 01/02/2026 | G0544A145 | 0.0 | <0.1% | 215,000 | Unchanged | |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | 0.0 | <0.1% | 10,000 | Unchanged | |
| Best Spac I Acquisition Corp | RIGHT 05/27/2030 | G1069P129 | 0.0 | <0.1% | 100,000 | New+100,000 | |
| Coherus Oncology IncCHRS | COM | 19249H103 | 0.0 | <0.1% | 10,366 | Unchanged |
Sold out: 80 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| 4D Molecular Therapeutics inFDMT | COM | 35104E100 | 0.0 | 0.0% | 0 | Sold out−116,712 | |
| Aclaris Therapeutics IncACRS | COM | 00461U105 | 0.0 | 0.0% | 0 | Sold out−132,426 | |
| Adicet Bio IncACET | COM NEW | 007002207 | 0.0 | 0.0% | 0 | Sold out−53,827 | |
| Alkermes plc | SHS | G01767105 | 0.0 | 0.0% | 0 | Sold out−46,400 | |
| Amicus Therapeutic | COM | 03152W109 | 0.0 | 0.0% | 0 | Sold out−105,000 | |
| Annexon IncANNX | COM | 03589W102 | 0.0 | 0.0% | 0 | Sold out−55,000 | |
| Apellis Pharmaceuticals Inc | COM | 03753U106 | 0.0 | 0.0% | 0 | Sold out−72,500 | |
| Aquestive Therapeutics IncAQST | COM | 03843E104 | 0.0 | 0.0% | 0 | Sold out−10,000 | |
| Arcellx Inc | COMMON STOCK | 03940C100 | 0.0 | 0.0% | 0 | Sold out−32,084 | |
| Arcturus Therapeutics HoldingsARCT | COM | 03969T109 | 0.0 | 0.0% | 0 | Sold out−15,000 | |
| Arrivent Biopharma IncAVBP | COM | 04272N102 | 0.0 | 0.0% | 0 | Sold out−141,814 | |
| Arrowhead Pharmaceuticals in | NOTE 1/1 | 04280AAC4 | 0.0 | 0.0% | 0 | Sold out−10,000 | |
| Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 0.0 | 0.0% | 0 | Sold out−25,014 | |
| Beam Therapeutics IncBEAM | COM | 07373V105 | 0.0 | 0.0% | 0 | Sold out−1,446,375 | |
| Belite Bio IncBLTE | SPONSORED ADS | 07782B104 | 0.0 | 0.0% | 0 | Sold out−26,880 | |
| Best Spac I Acquisition Corp | UNIT 05/27/2030 | G1069P137 | 0.0 | 0.0% | 0 | Sold out−100,000 | |
| Bioage Labs IncBIOA | COM | 09077V100 | 0.0 | 0.0% | 0 | Sold out−135,560 | |
| Bioatla Inc | COM | 09077B104 | 0.0 | 0.0% | 0 | Sold out−228,107 | |
| Bristol-Myers Squibb CoBMY | COM | 110122108 | 0.0 | 0.0% | 0 | Sold out−17,500 | |
| Centessa Pharmaceuticals plc | SPONSORED ADS | 152309100 | 0.0 | 0.0% | 0 | Sold out−38,566 | |
| Clover Health Investments CoCLOV | COM CL A | 18914F103 | 0.0 | 0.0% | 0 | Sold out−40,000 | |
| Corcept Therapeutics IncCORT | COM | 218352102 | 0.0 | 0.0% | 0 | Sold out−8,000 | |
| Core Scientific Inc NewCORZ | COM | 21874A106 | 0.0 | 0.0% | 0 | Sold out−30,000 | |
| Crowdstrike Holdings IncCRWD | CL A | 22788C105 | 0.0 | 0.0% | 0 | Sold out−640 | |
| Cullinan Therapeutics IncCGEM | COM | 230031106 | 0.0 | 0.0% | 0 | Sold out−50,000 | |
| DAY One Biopharmaceuticals I | COM | 23954D109 | 0.0 | 0.0% | 0 | Sold out−49,923 | |
| Design Therapeutics IncDSGN | COM | 25056L103 | 0.0 | 0.0% | 0 | Sold out−10,000 | |
| Dianthus Therapeutics IncDNTH | COM | 252828108 | 0.0 | 0.0% | 0 | Sold out−55,000 | |
| Elanco Animal Health IncELAN | COM | 28414H103 | 0.0 | 0.0% | 0 | Sold out−20,000 | |
| ELI Lilly & CoLLY | COM | 532457108 | 0.0 | 0.0% | 0 | Sold out−5,060 | |
| Engene Holdings Inc | COM | 29286M105 | 0.0 | 0.0% | 0 | Sold out−133,686 | |
| Erasca IncERAS | COM | 29479A108 | 0.0 | 0.0% | 0 | Sold out−10,000 | |
| Esperion Therapeutics Inc Ne | COM | 29664W105 | 0.0 | 0.0% | 0 | Sold out−21,400 | |
| Fractyl Health Inc | COM | 35168W103 | 0.0 | 0.0% | 0 | Call | Sold out−1,428,571 |
| Guardant Health IncGH | COM | 40131M109 | 0.0 | 0.0% | 0 | Sold out−10,000 | |
| Immix Biopharma IncIMMX | COM | 45258H106 | 0.0 | 0.0% | 0 | Sold out−10,000 | |
| Immunic Inc | COM | 4525EP101 | 0.0 | 0.0% | 0 | Sold out−30,000 | |
| Integer Holdings CorpITGR | COM | 45826H109 | 0.0 | 0.0% | 0 | Sold out−8,750 | |
| Intellia Therapeutics IncNTLA | COM | 45826J105 | 0.0 | 0.0% | 0 | Sold out−19,517 | |
| Jade Biosciences IncJBIO | COM NEW | 008064206 | 0.0 | 0.0% | 0 | Sold out−20,000 | |
| Jazz Pharmaceuticals plc | SHS USD | G50871105 | 0.0 | 0.0% | 0 | Sold out−3,000 | |
| Kala Bio Inc | COM NEW | 483119202 | 0.0 | 0.0% | 0 | Sold out−141,480 | |
| Kalvista Pharmaceuticals Inc | COM | 483497103 | 0.0 | 0.0% | 0 | Sold out−10,000 | |
| Karyopharm Therapeutics IncKPTI | COM NEW | 48576U205 | 0.0 | 0.0% | 0 | Call | Sold out−205,200 |
| Karyopharm Therapeutics IncKPTI | COM NEW | 48576U205 | 0.0 | 0.0% | 0 | Sold out−136,736 | |
| Kezar Life Sciences Inc | COM NEW | 49372L209 | 0.0 | 0.0% | 0 | Sold out−81,933 | |
| Kyntra Bio IncKYNB | COM NEW | 31572Q881 | 0.0 | 0.0% | 0 | Sold out−10,469 | |
| Kyverna Therapeutics IncKYTX | COM | 501976104 | 0.0 | 0.0% | 0 | Sold out−22,428 | |
| Legend Biotech CorpLEGN | SPONSORED ADS | 52490G102 | 0.0 | 0.0% | 0 | Sold out−20,000 | |
| Lipocine Inc NewLPCN | COM NEW | 53630X203 | 0.0 | 0.0% | 0 | Sold out−23,180 | |
| Liquidia CorporationLQDA | COM NEW | 53635D202 | 0.0 | 0.0% | 0 | Put | Sold out−100,000 |
| Masimo Corp | COM | 574795100 | 0.0 | 0.0% | 0 | Sold out−15,000 | |
| Mereo Biopharma Group plcMREO | SPON ADS | 589492107 | 0.0 | 0.0% | 0 | Sold out−150,000 | |
| Moonlake ImmunotherapeuticsMLTX | CLASS A ORD | 61559X104 | 0.0 | 0.0% | 0 | Call | Sold out−20,000 |
| Neurocrine Biosciences IncNBIX | COM | 64125C109 | 0.0 | 0.0% | 0 | Sold out−2,500 | |
| Nuvation Bio IncNUVB | COM CL A | 67080N101 | 0.0 | 0.0% | 0 | Sold out−43,500 | |
| Palo Alto Networks IncPANW | COM | 697435105 | 0.0 | 0.0% | 0 | Sold out−1,600 | |
| Q32 Bio IncQTTB | COM | 746964105 | 0.0 | 0.0% | 0 | Sold out−35,000 | |
| Quince Therapeutics Inc | COM | 22053A107 | 0.0 | 0.0% | 0 | Put | Sold out−50,000 |
| Quince Therapeutics Inc | COM | 22053A107 | 0.0 | 0.0% | 0 | Sold out−50,100 | |
| Regenxbio IncRGNX | COM | 75901B107 | 0.0 | 0.0% | 0 | Sold out−44,416 | |
| Replimune Group IncREPL | COM | 76029N106 | 0.0 | 0.0% | 0 | Call | Sold out−100,000 |
| Rubrik Inc.RBRK | CL A | 781154109 | 0.0 | 0.0% | 0 | Sold out−4,900 | |
| Scholar Rock HLDG CorpSRRK | COM | 80706P103 | 0.0 | 0.0% | 0 | Sold out−407,273 | |
| Schrodinger IncSDGR | COM | 80810D103 | 0.0 | 0.0% | 0 | Sold out−101,500 | |
| Sensient Technologies CorpSXT | COM | 81725T100 | 0.0 | 0.0% | 0 | Sold out−15,000 | |
| Soleno Therapeutics Inc | COM | 834203309 | 0.0 | 0.0% | 0 | Sold out−46,830 | |
| Surgery Partners IncSGRY | COM | 86881A100 | 0.0 | 0.0% | 0 | Sold out−20,000 | |
| Surrozen IncSRZN | COM NEW | 86889P208 | 0.0 | 0.0% | 0 | Sold out−12,000 | |
| Syndax Pharmaceuticals IncSNDX | COM | 87164F105 | 0.0 | 0.0% | 0 | Sold out−17,500 | |
| Teleflex IncorporatedTFX | COM | 879369106 | 0.0 | 0.0% | 0 | Sold out−21,186 | |
| Terns Pharmaceuticals Inc | COM | 880881107 | 0.0 | 0.0% | 0 | Call | Sold out−200,000 |
| Terns Pharmaceuticals Inc | COM | 880881107 | 0.0 | 0.0% | 0 | Sold out−914,699 | |
| The Oncology Institute IncSTLN | COM | 68236X100 | 0.0 | 0.0% | 0 | Sold out−50,000 | |
| Ultragenyx Pharmaceutical inRARE | COM | 90400D108 | 0.0 | 0.0% | 0 | Sold out−13,400 | |
| Uniqure NV | SHS | N90064101 | 0.0 | 0.0% | 0 | Call | Sold out−100,000 |
| Unitedhealth Group IncUNH | COM | 91324P102 | 0.0 | 0.0% | 0 | Sold out−5,501 | |
| Upstream Bio IncUPB | COM | 91678A107 | 0.0 | 0.0% | 0 | Sold out−35,000 | |
| Vertex Pharmaceuticals IncVRTX | COM | 92532F100 | 0.0 | 0.0% | 0 | Sold out−15,075 | |
| Viridian Therapeutics IncVRDN | COM | 92790C104 | 0.0 | 0.0% | 0 | Sold out−304,422 |
Source: SEC EDGAR, Form 13F-HR, accession 0001940272-26-000015 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.